ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Cancer Center at BIDMC announces launch of new Immunotherapy … – News-Medical.net

Continue reading

2018-05-04 Michael Zand NEWS

In Mice, CRISPR-based Alzheimer’s Therapies Inch Forward – Alzforum


News-Medical.net

Cancer Center at BIDMC announces launch of new Immunotherapy …
News-Medical.net
The Cancer Center at Beth Israel Deaconess Medical Center (BIDMC) today announced the launch of a new clinical and research institute that will build on BIDMC’s long history of leadership in immunotherapy and cell therapeutics. The Immunotherapy …
Cancer Center at BIDMC Launches Immunotherapy InstituteNewswise (press release)

all 5 news articles »

Continue reading

2018-05-04 Michael Zand NEWS

Editas Medicine Announces First Quarter 2018 Results and Update – Virginian-Pilot

Editas Medicine Announces First Quarter 2018 Results and UpdateVirginian-PilotAbout Editas Medicine As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cpf1 genome editing… Continue reading

2018-05-03 Michael Zand NEWS

Editas Medicine Announces First Quarter 2018 Results and Update – Virginian-Pilot

Editas Medicine Announces First Quarter 2018 Results and UpdateVirginian-PilotAbout Editas Medicine As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cpf1 genome editing… Continue reading

2018-05-03 Michael Zand NEWS

Editas Medicine Announces First Quarter 2018 Results and Update – GlobeNewswire (press release)

Macon DailyEditas Medicine Announces First Quarter 2018 Results and UpdateGlobeNewswire (press release)As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cpf1 genome edit… Continue reading

2018-05-03 Michael Zand NEWS

Editas Medicine Announces First Quarter 2018 Results and Update – GlobeNewswire (press release)

Macon DailyEditas Medicine Announces First Quarter 2018 Results and UpdateGlobeNewswire (press release)As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cpf1 genome edit… Continue reading

2018-05-03 Michael Zand NEWS

A transplant of CRISPR-edited liver cells could replace lifelong injections for hemophilia B patients – FierceBiotech

FierceBiotechA transplant of CRISPR-edited liver cells could replace lifelong injections for hemophilia B patientsFierceBiotechA Salk Institute team transplanted liver cells into mouse models of hemophilia B, finding that the treatment restored their a… Continue reading

2018-05-03 Michael Zand NEWS

Janssen strengthens immunotherapy capabilities with BeneVir acquisition – BioPharma-Reporter.com

BioPharma-Reporter.comJanssen strengthens immunotherapy capabilities with BeneVir acquisitionBioPharma-Reporter.comBeneVir is a biopharmaceutical company specializing in the development of oncolytic immunotherapies. Its proprietary T-Stealth Oncolytic … Continue reading

2018-05-03 Michael Zand NEWS
  • 1
  • …
  • 150
  • 151
  • 152
  • 153
  • 154
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

In Mice, CRISPR-based Alzheimer’s Therapies Inch Forward
Alzforum
What will it take before CRISPR/Cas gene editing technology might treat Alzheimer’s disease? Much more work, to be sure, but researchers are devising approaches, and grappling with the challenges of translating the technology from cells to animals, and …